170 related articles for article (PubMed ID: 21246525)
21. Randomized phase II trial of concurrent versus sequential bortezomib plus docetaxel in advanced non-small-cell lung cancer: a California cancer consortium trial.
Lara PN; Longmate J; Reckamp K; Gitlitz B; Argiris A; Ramalingam S; Belani CP; Mack PC; Lau DH; Koczywas M; Wright JJ; Shepherd FA; Leighl N; Gandara DR
Clin Lung Cancer; 2011 Jan; 12(1):33-7. PubMed ID: 21273177
[TBL] [